Hashimoto’s Thyroiditis is an autoimmune thyroid diseases (AITD) mediated by immune cells and antibodies, TPOAb and TgAb, leading to the destruction of the thyroid cells. The disease usually results in a decline in hormone production (hypothyroidism). Dysbiosis is Implicated in Hashimoto’s Disease A case control study found that the gut microbiota of Hashimoto’s patients differs […]
Hashimoto’s Thyroiditis (HT) was first discovered and reported by Professor Hashimoto of Kyushu University, Japan, in 1912, which led to the naming of the condition. Hashimoto’s Thyroiditis and Graves’ disease (GD) both fall under autoimmune thyroid diseases (AITD) and share similar pathogenic mechanisms, including thyroid lymphocytic inflammation and the presence of positive serum thyroid autoantibodies.
Graves’ disease is an autoimmune disorder that can cause hyperthyroidism, or an overactive thyroid. It results from an imbalance in the immune system, leading to the production of thyroid-stimulating antibodies [1]. It belongs to the group of autoimmune thyroid diseases (AITD), which also includes Hashimoto’s disease [2]. Graves’ disease is the most common cause of
Demystifying Graves’ Disease: Understanding the Role of TRAb in Diagnosis and Management Read More »
